Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

Total article views   HTML views PDF downloads Totals
6,309 Dovepress* 6,309+ 2,229 8,538
Totals 6,309 2,229 8,538
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar